Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Freeze Thaws: US FDA Allowed To Hire Staff For Cures, User Fee Activity

23 Mar 2017

• By Derrick Gingery

FDA entrance sign 2016

Related Content

CDER’s 50 Open Leadership Posts Could Be Bigger Hiring Challenges After Trump Freeze

02 Feb 2017

FDA Gets Broad Exemptions From Federal Hiring Freeze In HHS Memo

10 Feb 2017

US FDA May Find Relief From Trump's Hiring Freeze

02 Feb 2017

A Burning FDA Hiring Freeze Question: What About User Fee-Supported Staff?

24 Jan 2017

Trump's Budget Outline Threatens User Fee Agreements

17 Mar 2017

US Generic 'Breakthrough' Pathway Could Have Unintended Consequences

23 Mar 2017

FDA User Fee Hearing Hijacked By US Health Care Reform Arguments

22 Mar 2017

Rare Disease Integration Into FDA Reviews Will Grow Under PDUFA VI

18 Jul 2016

FDA's Breakthrough Workload Will Be Eased By Hiring Reviewers With PDUFA VI Funds

21 Jul 2016

Cures Bill Authorizes 'Intercenter Institutes,' But Will US FDA Create Them?

28 Nov 2016

US FDA Getting More Money Up Front Under Cures Bill Revisions

01 Dec 2016

The Evolution Of 21<sup>st</sup> Century Cures Legislation

30 Nov 2016

Additional Topics

United States FDA Legislation Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.